Editorial. Chronic convection-enhanced delivery: the next frontier in regional drug infusion for glioblastoma

View More View Less
  • UCSF Neurological Surgery, San Francisco, California
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00
Print or Print + Online

If the inline PDF is not rendering correctly, you can download the PDF file here.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00

Contributor Notes

Correspondence Manish K. Aghi: manish.aghi@ucsf.edu.

ACCOMPANYING ARTICLE DOI: 10.3171/2019.4.JNS19614.

INCLUDE WHEN CITING Published online August 2, 2019; DOI: 10.3171/2019.4.JNS19614.

Disclosures The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.

  • 1

    Barua NU, Woolley M, Bienemann AS, Johnson DE, Lewis O, Wyatt MJ, : Intermittent convection-enhanced delivery to the brain through a novel transcutaneous bone-anchored port. J Neurosci Methods 214:223232, 2013

    • Search Google Scholar
    • Export Citation
  • 2

    Bobo RH, Laske DW, Akbasak A, Morrison PF, Dedrick RL, Oldfield EH: Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci U S A 91:20762080, 1994

    • Search Google Scholar
    • Export Citation
  • 3

    Chang PD, Malone HR, Bowden SG, Chow DS, Gill BJA, Ung TH, : A multiparametric model for mapping cellularity in glioblastoma using radiographically localized biopsies. AJNR Am J Neuroradiol 38:890898, 2017

    • Search Google Scholar
    • Export Citation
  • 4

    D’Amico RS, Neira JA, Yun J, Alexiades NG, Banu M, Englander ZK, : Validation of an effective implantable pump-infusion system for chronic convection-enhanced delivery of intracerebral topotecan in a large animal model. J Neurosurg [epub ahead of print August 2, 2019. DOI: 10.3171/2019.3.JNS1963]

    • Search Google Scholar
    • Export Citation
  • 5

    Han SJ, Bankiewicz K, Butowski NA, Larson PS, Aghi MK: Interventional MRI-guided catheter placement and real time drug delivery to the central nervous system. Expert Rev Neurother 16:635639, 2016

    • Search Google Scholar
    • Export Citation
  • 6

    Jahangiri A, Chin AT, Flanigan PM, Chen R, Bankiewicz K, Aghi MK: Convection-enhanced delivery in glioblastoma: a review of preclinical and clinical studies. J Neurosurg 126:191200, 2017

    • Search Google Scholar
    • Export Citation
  • 7

    Kaiser MG, Parsa AT, Fine RL, Hall JS, Chakrabarti I, Bruce JN: Tissue distribution and antitumor activity of topotecan delivered by intracerebral clysis in a rat glioma model. Neurosurgery 47:13911399, 2000

    • Search Google Scholar
    • Export Citation
  • 8

    Lidar Z, Mardor Y, Jonas T, Pfeffer R, Faibel M, Nass D, : Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study. J Neurosurg 100:472479, 2004

    • Search Google Scholar
    • Export Citation
  • 9

    Okada H, Weller M, Huang R, Finocchiaro G, Gilbert MR, Wick W, : Immunotherapy response assessment in neuro-oncology: a report of the RANO working group. Lancet Oncol 16:e534e542, 2015

    • Search Google Scholar
    • Export Citation
  • 10

    Sampson JH, Archer G, Pedain C, Wembacher-Schröder E, Westphal M, Kunwar S, : Poor drug distribution as a possible explanation for the results of the PRECISE trial. J Neurosurg 113:301309, 2010

    • Search Google Scholar
    • Export Citation
  • 11

    Sonabend AM, Stuart RM, Yun J, Yanagihara T, Mohajed H, Dashnaw S, : Prolonged intracerebral convection-enhanced delivery of topotecan with a subcutaneously implantable infusion pump. Neuro Oncol 13:886893, 2011

    • Search Google Scholar
    • Export Citation
  • 12

    Vogelbaum MA, Aghi MK: Convection-enhanced delivery for the treatment of glioblastoma. Neuro Oncol 17 (Suppl 2):ii3ii8, 2015

  • 13

    Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, : Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 28:19631972, 2010

    • Search Google Scholar
    • Export Citation
  • 1

    Felsberg J, Thon N, Eigenbrod S, Hentschel B, Sabel MC, Westphal M, : Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas. Int J Cancer 129:659670, 2011

    • Search Google Scholar
    • Export Citation
  • 2

    Kim J, Lee IH, Cho HJ, Park CK, Jung YS, Kim Y, : Spatiotemporal evolution of the primary glioblastoma genome. Cancer Cell 28:318328, 2015

    • Search Google Scholar
    • Export Citation
  • 3

    Schafer N, Gielen GH, Rauschenbach L, Kebir S, Till A, Reinartz R, : Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors. J Transl Med 17:96, 2019

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 213 213 213
Full Text Views 85 85 85
PDF Downloads 32 32 32
EPUB Downloads 0 0 0